NCT00338936View on ClinicalTrials.gov

Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)

PHASE3CompletedINTERVENTIONAL

Enrollment

362

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Hypertension

Interventions

DRUG

Valsartan + Hydrochlorothiazide

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY